NASDAQ
BridgeBio Pharma, Inc. (BBIO) has a interest coverage ratio of -10.72x as of Friday, May 29, 2026. This represents a 33.38% decrease compared to its 12-month average of -8.03x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.